Skip to main content

CollPlant Biotechnologies Ltd

CLGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001631487

No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding CollPlant Biotechnologies Ltd changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CLGN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders1516+1
Shares1.81M2.45M+633.3K (+34.9%)
Value$24.4M$51.9M+$27.5M (+112.9%)

New holders (6)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CLGN in Q2 2021
InstitutionSharesValue% of portfolio
Roumell Asset Management, LLC563,030$11.9M13.95%
State Street Corp176,490$3.74M0.00%
Citadel Advisors LLC13,034$276.0K0.00%
ACT Capital Management, LLC7,500$160.0K0.08%
Tower Research Capital LLC (TRC)597$13.0K0.00%
Morgan Stanley150$3.00K0.00%

Sold out (5)

Institutions that held CollPlant Biotechnologies Ltd at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of CLGN in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Brown Advisory Inc54,650$734.0K
Sigma Planning Corp19,700$265.0K
Sabby Management, LLC17,045$229.0K
Royal Bank of Canada10,000$134.0K
Sandy Spring Bank117$2.00K